Back
Kelly Services 10K Form
Sell
30
KELYA
Kelly Services
Last Price:
14.20
Seasonality Move:
6.42%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-09 | 10Q | KELYA/Kelly Services Quarterly |
2023-11-09 | 10Q | KELYA/Kelly Services Quarterly |
2023-08-10 | 10Q | KELYA/Kelly Services Quarterly |
2023-05-11 | 10Q | KELYA/Kelly Services Quarterly |
2022-11-10 | 10Q | KELYA/Kelly Services Quarterly |
2022-08-11 | 10Q | KELYA/Kelly Services Quarterly |
Receive KELYA News And Ratings
See the #1 stock for the next 7 days that we like better than KELYA
KELYA Financial Statistics
Sales & Book Value
Annual Sales: | $4.84B |
---|---|
Cash Flow: | $-22.7M |
Price / Cash Flow: | 11.94 |
Annual Sales: | $36.04 |
Price / Book: | 0.4 |
Profitability
EPS (TTM): | 1.15000 |
---|---|
Net Income (TTM): | $42.6M |
Gross Margin: | $961.4M |
Return on Equity: | 3.37% |
Return on Assets: | 1.66% |
Kelly Services Earnings Forecast
Key Kelly Services Financial Ratios
- The Gross Profit Margin over the past 40 years for KELYA is 19.88%.
- The Selling, General & Administrative Expenses for KELYA have been equal to 19.33% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 8.79% of Operating Income.
- The Net Earning history of KELYA is 0.75% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 27 years.
Kelly Services Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Professional Services |
Sector: | Industrials |
Current Symbol: | KELYA |
CUSIP: | 488152 |
Website: | kellyservices.com |
Debt
Debt-to-Equity Ratio: | 0.18 |
---|---|
Current Ratio: | 1.61 |
Quick Ratio: | 1.52 |
Price-to-Earnings
Trailing P/E Ratio: | 14.68 |
---|---|
Forward P/E Ratio: | 5.49 |
KELYA Technical Analysis vs Fundamental Analysis
Sell
30
Kelly Services (KELYA)
is a Sell
Is Kelly Services a Buy or a Sell?
-
Kelly Services stock is rated a Sell
The current Kelly Services [KELYA] share price is $14.39. The Score for KELYA is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.